Troubles neuropsychiatriques inexpliqués : penser aux encéphalites dysimmunitaires. À propos d’une observation d’encéphalite à anticorps anti-leucine rich glioma inactivated 1 (LGI-1)
- 8 July 2015
- journal article
- case report
- Published by Elsevier BV in La Revue de Médecine Interne
- Vol. 37 (2), 127-130
- https://doi.org/10.1016/j.revmed.2015.06.007
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Therapeutic approaches in antibody-associated central nervous system pathologiesRevue Neurologique, 2014
- Cell‐surface central nervous system autoantibodies: Clinical relevance and emerging paradigmsAnnals of Neurology, 2014
- Pathognomonic seizures in limbic encephalitis associated with anti-LGI1 antibodiesThe Lancet, 2014
- Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotypeBrain, 2013
- Encéphalites dysimmunitaires, données cliniques, radiologiques et immunologiquesRevue Neurologique, 2013
- Autoantibodies associated with diseases of the CNS: new developments and future challengesThe Lancet Neurology, 2011
- Faciobrachial Dystonic Seizures Precede Lgi1 Antibody Limbic EncephalitisAnnals of Neurology, 2011
- Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case seriesThe Lancet Neurology, 2010
- Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotoniaBrain, 2010
- Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitisBrain, 2004